FT4 METHOD FOR THE DIMENSION RXL CLINICAL CHEMISTRY SYSTEM— 510(k) K971141

Name: FDA 510(k) clearance K971141
Creator: U.S. Food and Drug Administration
Published: 1997-04-28

Substantially Equivalent

Dade Chemistry Systems, Inc.

FDA 510(k) clearance K971141 for FT4 METHOD FOR THE DIMENSION RXL CLINICAL CHEMISTRY SYSTEM, Substantially Equivalent on 1997-04-28. Applicant: Dade Chemistry Systems, Inc.. Device class: 2.

Clearance details

Applicant: Dade Chemistry Systems, Inc.
Product code: Code CEC
Device class: Class 2
Regulation: 21 CFR 862.1695
Advisory panel: Clinical Chemistry
Date received: 1997-03-28
Decision date: 1997-04-28
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Newark, DE, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code CEC

view all

K240273 — Access Free T42024-03-06
K220456 — Elecsys FT4 IV2023-04-07
K182423 — MAGLUMI 2000 FT42018-10-04
K181233 — Elecsys FT4 III2018-09-18
K173122 — Abbott Architect Free T42017-10-27

More clearances from Dade Chemistry Systems, Inc.

view all

K973650 — TROPONIN (TROP) METHOD1997-10-20
K973099 — PROSTATE SPECIFIC ANTIGEN CONTROL1997-09-29
K973100 — PROSTATE SPECIFIC ANTIGEN (PSA) CALIBRATOR1997-09-29
K973101 — PROSTATE SPECIFIC ANTIGEN METHOD1997-09-18
K970387 — HUMAN CHORIONIC GONADOTROPIN METHOD1997-03-10

Adverse events under product code CEC

product code CEC

Malfunction: 899
Total: 899

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.